International Edition
World Markets FX Policy

Saturday, 24 October 2026

Private Trade News

Global markets, trading & world business — for professional traders

Trading

FDA Approves Eli Lilly's Mounjaro To Reduce Cardiovascular Risk In Type 2 Diabetes

Private Trade News trader edition (2026-08-28): (RTTNews) - Eli Lilly and Co. (LLY), a pharmaceutical company, announced Friday that the U.S. Food and Drug Administration (FDA) approved Mounjaro… Primary source: original at Nasdaq Market Structure (nasdaq.com).

· Nasdaq Market Structure

FDA Approves Eli Lilly's Mounjaro To Reduce Cardiovascular Risk In Type 2 Diabetes

(RTTNews) - Eli Lilly and Co. (LLY), a pharmaceutical company, announced Friday that the U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) to lower the risk of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack

Read at source

Read also